Home > Insider Trading > Filing (0001209191-21-021189)

Filing Details

Accession Number:: 0001209191-21-021189
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-16 20:20:15
Reporting Period:: 2021-03-12

Accepted Time:: 2021-03-16 20:20:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
70318	Tenet Healthcare Corp	THC	Services-General Medical & Surgical Hospitals, Nec (8062)	952557091

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1396106	J Daniel Cancelmi	14201 Dallas Parkway Dallas TX 75254	Evp & Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-12	37,500	$25.08	399,500	No	4	M	Direct
Common Stock	Disposition	2021-03-12	37,500	$55.22	362,000	No	4	S	Direct
Common Stock	Acquisiton	2021-03-12	89,976	$18.99	451,976	No	4	M	Direct
Common Stock	Disposition	2021-03-12	83,573	$55.25	368,403	No	4	S	Direct
Common Stock	Disposition	2021-03-12	6,403	$56.05	362,000	No	4	S	Direct
Common Stock	Acquisiton	2021-03-12	16,126	$20.60	378,126	No	4	M	Direct
Common Stock	Disposition	2021-03-12	16,126	$55.32	362,000	No	4	S	Direct
Common Stock	Acquisiton	2021-03-15	70,700	$20.60	432,700	No	4	M	Direct
Common Stock	Disposition	2021-03-15	9,750	$55.67	422,950	No	4	S	Direct
Common Stock	Disposition	2021-03-15	27,891	$56.61	395,059	No	4	S	Direct
Common Stock	Disposition	2021-03-15	33,059	$57.29	362,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	2012 September Stock Options (Right to Buy)	Disposition	2021-03-12	37,500	$25.08	37,500	$25.08
Common Stock	2017 March Performance Stock Options (Right to Buy)	Disposition	2021-03-12	89,976	$18.99	89,976	$18.99
Common Stock	2018 February Performance Stock Options (Right to Buy)	Disposition	2021-03-12	16,126	$20.60	16,126	$20.60
Common Stock	2018 February Performance Stock Options (Right to Buy)	Disposition	2021-03-15	70,700	$20.60	70,700	$20.60

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2022-09-28	No	4	M	Direct
0	2027-03-01	No	4	M	Direct
70,700	2028-02-28	No	4	M	Direct
0	2028-02-28	No	4	M	Direct

Footnotes

All historical share data in this Form 4 have been restated to reflect a one-for-four reverse stock split, effective as of October 11, 2012.
This stock option was exercised and the resulting shares were sold in open market broker transactions, the proceeds of which were used in part to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to broker-assisted cashless exercises and sales.
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $54.53 to $55.45. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $54.56 to $55.55. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $55.56 to $56.52. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $55.05 to $55.38. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $55.06 to $56.00. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $56.06 to $57.06. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $57.09 to $57.62. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
These derivative securities (stock options) vested and became exercisable on each of September 27, 2013 (the business day prior to the first anniversary date, which fell on a weekend), September 26, 2014 (the business day prior to the second anniversary date, which fell on a weekend) and September 28, 2015.
These derivative securities (stock options) vested and became exercisable on February 28, 2020 (the business day prior to March 1, 2020, which fell on a weekend).
These derivative securities (stock options) vested and became exercisable on February 26, 2021 (the business day prior to February 28, 2021, which fell on a weekend).